Overview
Also known as:
Clinical phenotype terms— hover any for plain English:
FDA & Trial Timeline
10 eventsMilitary University Hospital, Prague — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Nodular regenerative hyperplasia of the liver.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Nodular regenerative hyperplasia of the liver at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Nodular regenerative hyperplasia of the liver.
Community
No community posts yet. Be the first to share your experience with Nodular regenerative hyperplasia of the liver.
Start the conversation →Latest news about Nodular regenerative hyperplasia of the liver
Disease timeline:
New recruiting trial: Prediction of Portal Hypertension in Patients With CVID (CVID-pHT)
A new clinical trial is recruiting patients for Nodular regenerative hyperplasia of the liver
New recruiting trial: Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)
A new clinical trial is recruiting patients for Nodular regenerative hyperplasia of the liver
New recruiting trial: Non-invasive Tools for PSVD Diagnosis
A new clinical trial is recruiting patients for Nodular regenerative hyperplasia of the liver
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Nodular regenerative hyperplasia of the liver
Which specialists treat Nodular regenerative hyperplasia of the liver?
6 specialists and care centers treating Nodular regenerative hyperplasia of the liver are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.